Showing results (1-10 of 221) with videos related to
Sort By:
Pageof 23
Current Opinion in Obstetrics & Gynecology|December 30, 2021
Changing treatments paradigms and role of immunotherapy in recurrent endometrial cancerAnca Chelariu-Raicu, Haider Mahdi, Brian M SlomovitzInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2023
Immunotherapy in endometrial cancerHaider Mahdi, Anca Chelariu-Raicu, Brian M SlomovitzChirurgia (Bucharest, Romania : 1990)|December 30, 2021
Treatment Landscape of Ductal Carcinoma In SituAnca Chelariu-Raicu, Nadia HarbeckChinese Clinical Oncology|August 22, 2020
Breast cancer (BRCA) gene testing in ovarian cancerAnca Chelariu-Raicu, Robert L ColemanInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 6, 2020
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancerBrian M Slomovitz, Anca Chelariu-Raicu, Kathleen M Schmeler, et al.Current Opinion in Obstetrics & Gynecology|December 14, 2020
Current and future landscape of poly (ADP-ribose) polymerase inhibition resistanceEmily Hinchcliff, Anca Chelariu-Raicu, Shannon N WestinInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 2, 2021
Fertility preservation in rare ovarian tumorsAnca Chelariu-Raicu, Lauren P Cobb, David M GershensonOncology (Williston Park, N.Y.)|August 1, 2019
Anti-Angiogenesis Therapy in Ovarian Cancer: Which Patient is It Most Likely to Benefit?Anca Chelariu-Raicu, Robert L Coleman, Anil K SoodInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 10, 2020
Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancerAnca Chelariu-Raicu, Charles F Levenback, Brian M Slomovitz, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 15, 2020
The new world of poly-(ADP)-ribose polymerase inhibitors (PARPi) used in the treatment of gynecological cancersAnca Chelariu-Raicu, Graziela Zibetti Dal Molin, Robert L ColemanPageof 23